Sort by
Refine Your Search
-
Category
-
Field
-
of Arts, Masaryk University announces an open competition for the position: Researcher Workplace: Department of Classical Studies, Faculty of Arts, Masaryk University EU Researcher Profile: R2 Amount
-
Job field: Science and research Dean of the Faculty of Arts, Masaryk University announces an open competition for the position: Researcher Workplace: RE:CENT (Center for Medieval Visual Cultures and
-
insights into the role of lipid asymmetry in biological membranes and its influence on membrane protein function, with potential applications in the development of lipid-targeted therapeutics and biosensors
-
for more effective treatments. One promising strategy involves mRNA-based cancer immunotherapy vaccines, which require a drug delivery system capable of reliably reaching the cytosol. Developing
-
further education and professional development Benefits package: 6 weeks of paid holiday, medical insurance, financial contribution to meal and kindergarten/pension scheme, Multisport card, mental health
-
peptides, including the design of de novo sequences based on the elucidated mechanism. The first step will be to develop a computational approach to determine the critical peptide properties required
-
Department: Department of Czech Language – Faculty of Arts Job field: Science and research Dean of the Faculty of Arts, Masaryk University announces an open competition for the position: Researcher
-
research Dean of the Faculty of Arts, Masaryk University announces an open competition for the position: Researcher Workplace: Department of German, Scandinavian and Netherland Studies, Faculty of Arts
-
research Dean of the Faculty of Arts, Masaryk University announces an open competition for the position: Researcher Workplace: Department of German, Scandinavian and Netherland Studies, Faculty of Arts
-
offer key insights into the role of lipid asymmetry in biological membranes and its influence on membrane protein function, with potential applications in the development of lipid-targeted therapeutics